antidepressants
Coverage of antidepressants in the Nexus archive.
- Quitting Antidepressants: From Withdrawal to Tapering One Step at a Time
A new federal initiative has brought attention to the complexities of stopping antidepressant use among Americans. Psychiatrist Jonathan Slater highlighted that safely tapering off these medications requires individualized, monitored care due to a lack of guidelines. The article notes that British author Madeline Dyer successfully used an antidepressant for mental health issues but reported it impacted her genre choice.
- How millions of patients taking antidepressants may be at risk of a sudden fatal heart event... yet doctors are failing to warn them about it. What EVERY person on the medication needs to know
Millions of patients taking antidepressants may be at risk of sudden fatal heart events, and doctors are failing to warn them. The article emphasizes the importance of awareness for individuals on the medication.
- Why patients taking antidepressants long-term may be at risk of sudden cardiac arrest: The pills are now prescribed to 9million a year - yet doctors are failing to warn people about this serious side effect
Patients taking antidepressants long-term may face a risk of sudden cardiac arrest, with 9 million prescriptions issued annually. Doctors are reportedly failing to warn patients about this serious side effect.
- Jurors in Lindsay Clancy's trial visit the home where she killed her children
Jurors in Lindsay Clancy's trial visited the Massachusetts home where she killed her three children, including the basement where they died and the yard where she was found after jumping from a window. Clancy's defense claims she was suffering from postpartum psychosis, while prosecutors argue she acted intentionally.
- The Real Antidepressant Crisis
Robert F. Kennedy Jr. criticizes the overprescription of antidepressants, advocating for de-prescribing SSRIs despite patient concerns about their benefits. The article discusses the debate around their effectiveness for moderate-to-severe depression versus everyday distress, noting 17% of American adults use antidepressants.
- Early Addition: This summer, the campers are medicated
Campers on GLP-1 medications and antidepressants are increasing the workload for camp doctors this summer. Additional topics include rent-stabilized tenants, illegal puppy sellers in Manhattan, and calls to boycott a Rockaway beach club.
- Millions warned that popular summer fruit can seriously interfere with medications
Grapefruit consumption can interfere with medications like statins and antidepressants by inhibiting the CYP3A4 enzyme, leading to dangerously high drug concentrations and potential side effects such as muscle cramps, dizziness, and extreme drowsiness. Even small amounts of grapefruit or juice can have a prolonged effect, lasting up to 72 hours.
- STAT+: HHS presses ahead with effort to curb antidepressant use
Health Secretary Robert F. Kennedy Jr. is advancing an initiative to help Americans reduce or stop antidepressant use through deprescribing efforts. Federal health officials and mental health professionals discussed clinical guidance for tapering antidepressants, reviewed European practices, and explored nonmedication options like therapy. The talks highlighted gaps in research on SSRI side effects and distinguishing them from depressive symptoms.
- Heat is especially hard on people taking antidepressants
High temperatures can increase the risk of dizziness, dehydration, exhaustion, and other heat-related problems for people taking antidepressants. The article highlights the specific challenges faced by individuals on antidepressants during extreme heat.
- Why certain medications can increase your risk in the heat
Certain medications for heart disease, high blood pressure, and kidney issues can impair the body's ability to manage heat, increasing risks of dehydration, overheating, and severe health complications during heatwaves. Experts advise continuing medication use but emphasize proactive cooling measures like air conditioning, hydration, and avoiding sun exposure.
- Federal prisons must provide hormones sought by trans inmates
Federal prisons are required to provide hormones to transgender inmates. The government previously argued that changing medical consensus justified using psychotherapy and antidepressants instead of hormone treatment for trans inmates.
- Antidepressants and antipsychotics could serve as alternatives to opioids, study finds
A study suggests that antidepressants and antipsychotics could serve as pain relief alternatives to opioids in emergency departments. The research reviewed non-opioid medications available at San Francisco General Hospital and analyzed existing medical literature to identify potential options for treating pain without opioids' addictive risks.
- Single infusion of controversial drug changed severe depression symptoms within hours, study finds
A study reviewed 26 clinical trials involving over 1,100 patients, finding that a single ketamine infusion significantly reduced severe depression symptoms within four hours and lowered suicidal thoughts within 24 hours. The analysis suggests ketamine may offer rapid relief for treatment-resistant depression, though it carries risks like dissociation and nausea.
- Antidepressant Maker Seaport Raises $255 Million in Upsized IPO
Seaport, an antidepressant manufacturer, raised $255 million in an upsized IPO. The article also mentions BioTech USA Kft., a European food supplement manufacturer, and its production facility in Hungary.
- Health chiefs issue urgent recall for antidepressants prescribed to millions due to manufacturing error: 'Seek medical advice immediately'
Health authorities have issued an urgent recall of antidepressants prescribed to millions due to a manufacturing error. Patients are advised to seek immediate medical advice as a precaution.
- Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO
Seaport, an antidepressant drugmaker, is seeking $212.4 million through a U.S. initial public offering (IPO). The company aims to raise capital as part of its expansion plans in the pharmaceutical sector.
- Common IBS medications linked to higher risk of death in major study
A 20-year study of over 650,000 Americans with IBS found that common treatments like antidepressants and antidiarrheal drugs were linked to a small but increased risk of death over time. The findings raise concerns about the long-term safety of these medications.